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Quantitation of Dendritic Cells in Normal and Abnormal Human 
Epidermis Using Monoclonal Antibodies Directed Against Ia and HTA 
Antigens 
RONA M . MACKIE, M .D. AND MARLYN L. TURBITT, PH.D. 
Department of Dermatology, University of Glasgow, Glasgow, Scotland 
Two monoclonal antibodies, NAI 34 and DA6 231, 
have been used as surface markers to count epidermal 
Langerhans cells in normal skin, allergic contact der-
matitis, and mycosis fungoides of the plaque and poiki-
lodermatous varieties. The antibodies recognized the 
HT A (human thymocyte antigen) and Ia antigens, re-
spectively. In all situations the numbers of cells labeled 
by the two antibodies differed. In normal skin 75% of 
dendritic cells were labeled by both antibodies and 25% 
were labeled by N AI 34 alone. In contact dermatitis 
there is an increase in dendritic cells labeled by both 
antibodies and this pattern is also seen in untreated 
plaque stage mycosis fungoides. In poikilodermatous 
mycosis fungoides, striking staining of the epidermal 
keratinocytes with DA6 231 is seen with no dendritic 
cells labeled. Dendritic cells are, however, clearly seen 
with N AI 34 staining. Numbers of dendritic cells labeled 
by both antibodies fall during PUV A therapy. 
In 1977 it was reported that the only cell in normal human 
epidermis to bear Ia antigen was the Langerhans cell [1-3]. 
Since that time Ia antigen has been used as a marker for 
Langerhans cells in both normal and pathologic epidermis. 
More recently two groups have reported that monoclonal anti-
HTA1 antibody· (OKT6 and NAI 34) raised against mature 
cortical thymocytes also reacts with human Langerhans cells 
[4,5] . These particular monoclonal antibodies have also been 
shown by ultrastructural surveys to react with the indetermi-
nate dendritic cell population of the epidermis and dermis [4]. 
We have utilized both Ia and HTA (human thymocyte anti-
gen) antibodies for quantitative morphologic immunopatho-
logic studies of the Langer hans cell and indeterminate dendritic 
cell population in normal skin, mycosis fungoides prior to and 
after photochemotherapy, and contact dermatitis. Clear dis-
crepancies in the numbers of labeled cells counted by the two 
antibodies are seen. 
MATERIALS AND METHODS 
Details of patients studied are given in Table I. All skin biopsies 
were snap-frozen, stored at - 2o·c, and tested within. 10 days of 
excision. Sections were cut at 4- 6 ~tm on a cryostat and no fixation 
used. They were incubated for 60 min after overlaying anti-Ia antibody 
at a dilut ion of 1:100 or anti-HTA at 1:1000. After brief washing with 
0.1 M Tris buffer, pH 7.6 (used for aU washes), the sections were treated 
with 1:20 rabbi t antimouse peroxidase lgG (Dako) for 45 min . After 
further washing the sections were immersed in 0.03% diaminobenzidine 
and 0.01% H,O, for 8 min. In some instances a double-labeling tech-
nique was used with a second antibody incubated for 60 min followed 
by rabbit antimouse peroxidase in the same manner. The reaction in 
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this case was visualized by 0.03% 4-chloronaphthol and 0.01 % H20 ,. 
The number of stained dendritic epidermal cells above 200 basal 
layer keratinocytes and per linear mm of epidermis was counted by 2 
independent observers. Statistical analysis was carried out using the 
Student t-test and Mann-Whit ney-Wilcoxon test where appropr iate. 
In certain skin samples, notably poikilodermatous mycosis fun-
goides, strong staining of the membrane of epidermal keratinocytes 
with Ia ant ibody was noted. This was graded on a 0- 4 basis: 0 = no 
keratinocyte staining, 1 = fa int positive staining but patchy, 2 = 
stronger positive staining but still patchy, 3 = faint uniform staining, 
and 4 = strong uniform staining throughout the sample. 
Monoclonal Antibodies Used 
The HTA antibody used in this study was kindly provided by Dr. A. 
J. McMichael of Oxford. Full details of the anti t hymocyte specificity 
have been published [6] and its reactivity with Langerhans cells [5] 
has also been reported. The Ia antibody used was provided by Drs. K. 
Guy and V. Van Heyningen, of Edinburgh. This antibody (DA6 231) 
reacts predominantly with the {3 chain of the HLA molecule [7- 9]. 
RESULTS 
Normal Skin 
The numbers of Ia- and HTA-stained dendritic cells per 200 
basal layer keratinocytes and per linear mm of epidermis is 
shown in Table I. It is clear that the number of cells stained 
by the two antibodies differ. In the 4 normal skin samples 
studied, the mean of !a-stained dendritic cells is 28 ± 7/200 
basal cells or 15/linear mm, while that for HTA-positive den-
dritic cells is 39 ± 3 or 21/mm. Staining of sequential sections 
from the one block (Figs 1, 2) and also double-labeling tech-
niques clearly indicate that the majority of !a-positive cells also 
stained with HTA, but that approximately 25% of the HTA-
positive cells stained only with this antibody and not with Ia . 
Allergic Contact Dermatitis 
The 5 samples from positive patch tests biopsied 48- 72 h 
after application of the known sensitizing agent indicate that 
t he numbers of both Ia- and HTA-positive cells are significant ly 
increased over values for normal skin (p > 0.01) . The figures 
are 43 ± 11 for !a-positive and 59 ± 17 for HTA-positive cells. 
As with t he normal skin samples, we clearly see two populations 
of dendritic cells, one t hat stains with both Ia and HT A 
antibodies and the other t hat stains only with HT A. A striking 
finding in the !a-stained preparations from these biopsies is 
the staining of epidermal keratinocyte membranes in addition 
to the clearly delineated epidermal dendritic cells·. This staining 
is generally patchy but dense (Fig 3) and is shown to be specific 
by omission of first or second layers of antibody as controls 
and by limiting dilution . This type of keratinocyte membrane 
staining was not observed with HTA antibody on any sample 
·or with the Ia antibody in normal skin. 
Mycosis Fungoides (Plaque Type) 
These biopsies are divided into samples from those receiving 
no therapy, the majority taken prior to any form of treatment, 
and those from patients on photochemotherapy (PUVA). In 13 
biopsies from pretreatment patients the mean value for !a-
positive dendritic cells is 33 ± 10 and for HTA-positive cells is 
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TABLE I. Numbers of fa- and HTA -positive cells in normal and diseased epidermis 
Group Age No. of Topical !a-positive HTA-positive !a-positive Disease cells/ 200 cells/200 no. range patients therapy basal cells" basal cells" kera ti nocytes 
1 Normal skin 22- 64 4 28±7(SD) 39 ± 3 0 
(15) (21) 
2 Allergic contact 38- 59 (44) 5 43 ± 11 59± 12 3 
dermatitis (23) (32) 
3 P laque stage 28- 71 (58) 14 Pretherapy 33 ± 10 49 ± 11 3 
mycosis (18) (27) 
fungoides 
4 Poikilodermatous 29- 42 (40) 4 Pretherapy None seen 46 ± 12 4 
mycosis (25) 
fungo ides 
5 Mycosis 46- 72 (51) 11 6- 16 days 23 ± 10 37 ± 13 2 
fungoides on after PUVA (13) (20) 
PUVA 
"Figu res in parentheses refer to number of cells/linear mm of epidermis. 
FIG 1. A, NAI 34 stained normal skin showing profuse regularly 
stained Langerhans cells in t he midepidermis. Posit ively stained cells 
are exceptionally rare in the dermis. B, Adjacent section stained with 
DA6 231 showing fewer stained cells in t he same midepidermal area. 
Note the !a-posit ive cells within a dermal capillary. A and B, X 250. 
49 ± 14. These are both increases over the norma l levels but 
not statistically s ignificant. (Fig 4) 
Eleven biopsies from mycos is fungoides patients on PUV A 
are available a nd figures here are 23 ± 7 for !a-positive cells 
and 37 ± 13 for HTA-positive cells. In both cases t his represents 
a s ignifican t drop by comparison with pretreatment values. In 
4 pat ients pairs of sequential · biopsies a re available, 2 from 
patients who received PUV A after t he first biopsy and before 
t he second a nd 2 from patien ts who did not receive PUV A 
between t he 2 biopsies. The figures shown in Table II indicate 
clear ly a fall in the number of both populations of dendritic 
cells in t he case of PUVA-treated patients but a rise in the 2 
A 
FIG 2. A, Higher power view of normal skin showing NA l 34 tained 
dendritic epidermal cells. Note again total absence of dermal staini ng. 
B, Adjacent section stained with DA6 231 showi ng fewer epidermal 
dendritic cells and underlying posit ive dermal cells. A and B, X 400. 
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F IG 3. A, Positive patch test showing an increase in the number of 
NAI 34 stained epidermal dendritic cells. B, Adjacent section stained 
with DA6 231 showing str iking intercellular epidermal keratinocyte 
staining adjacent to a sweat duct. The keratinocytes a round the sweat 
duct do not show Ia staining. A population of !a-positive lymphoid 
cells- presumably ".activated" T lymphocytes-is seen in the underly-
ing dermis. A and B, x 125. 
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patients who did not receive PUV A. In all cases the interval 
between exposure to UV A and biopsy was as long as possible 
(6- 16 days) to allow for recovery of dendritic cells reported to 
be either unlabeled or temporarily reduced in numbers after 
PUVA therapy [10]. 
As with contact dermatitis cases, we found evidence of patchy 
Ia stain ing on epidermal keratinocytes. This varied in intensity 
from 1 to 3 and was sti ll present on some PUV A-treated 
samples but with a tendency to be less strong (0 to 2). 
Mycosis Fungoides (Poiki lodermatous Variety) 
Biopsy samples from 4 patients with the poikilodermatous 
variety of mycosis fungoides were studied and here the most 
striking differences between the staining patterns of the 2 
antibodies were seen. No clearly defined !a-positive dendritic 
cells were seen in any sample although Ia staining of keratin-
ocyte membrane was present in all samples in a strong regular 
pattern (4+) (Fig 5). In contrast, the HTA-positive dendritic 
cells were present in numbers statistically significantly raised 
above normal leve ls (47 ± 13). It is possible that the strongly 
positive Ia keratinocyte staining could obscure positive dendri-
t ic cells but double staining with anti-Ia followed by HTAl 
TABLE II. HTA - a.nd !a.-stained epidermal cells in four mycosis 
fungoides patients 
[a-positive HTA-positive [a-positive dendritic dendritic 
cells cells keratinocytes 
Non treated patients A r•mpi•I 14 45 2+ Sample 2 20 66 2+ 
B Sample 1 24 54 4+ 
Sample 2 50 58 3+ 
PUVA-treated patients 
c r•mplo! 40 52 2+ Sample 2 16 -28 1+ 
D Sample 1 36 56 0 
Sample 2 20 26 0 
F IG 4. A, Mycosis fungoides, plaque stage. NAI 34 stained epidermis showing an increase in positively stained epidermal dendritic cells. B, 
Adjacent section stained with DA6 231 showing a smaller number of positive epidermal dendritic ce lls and patchy positive intercellular 
keratinocyte staining. A and B, x 400. 
S ept. 1983 
FIG 5. A, Poikilodermatous mycosis fun goides stained wit h NA! 34 
showing epidermal atrophy and posit ive ly stained dendri t ic ce lls. B, 
Adjacent DA6 231 stai ned section showing gross (grade 4) epidermal 
inte rcellular keratinocyte staining and underlying !a-positive lymphoid 
cells in the papillary dermis. No epidermal dendri t ic cells can be 
ident ified. A a nd B, x 125. 
resulted in HTA1 -posit ive dendri t ic cells and !a-posit ive kera-
t inocyte membranes , demonstrating that the anti -Ia is not 
labeling t he dendrit ic ce lls (Fig 5). 
DISCUSSION 
This study shows that t he 2 ant ibodies used to delineate 
Langerhans cell populations do not label ident ical dendri t ic 
epidermal cell populations eit her in normal or in diseased skin . 
This is of importance, as there is an increasing tendency to use 
eit her HTA or Ia ant ibodies interchangeably as a marker fo r 
Langerhans cells. It is apparent that in normal epidermis 25% 
of the dendritic cells ident ified stain only with HTA and not 
with la. These may t herefore be dendri t ic cells t hat lack the 
ant igen-present ing capacity of the !a-posit ive population, a 
function recognized to date only in cells t hat bear Ia ant ige n. 
The true dendri t ic nature of these exclusively HTA-posit ive 
epidermal cells is clearly shown in Fig 1. This characteristic 
shape together wit h the relatively large numbers would, we fee l, 
rule out the possibili ty t hat lymphocytes "trafficking" t hrough 
the epidermis have temporarily acquired HTA ant igen. T he 
ratio of double-stained to HTA-only cells in normal skin is 3:1. 
In the allergic contact dermatit is samples there appears to 
be a clear increase at 48 h in the numbers of both populations 
of epidermal dendri t ic cells. The ratio of double-stained cells 
to HTA of 3:1 is, however, preserved, suggesting that even 
under the well -defined stimulus of application of a known 
sensit izer the entire epidermal dendri t ic cell population does 
not temporari ly become !a-posit ive. In view of t he known 
acquisit ion ofla ant igen by "activated" T lymphocytes [11] this 
is an important observation . 
In t he nonpoikilodermatous mycosis fungoides patients prior 
to PUVA the numbers of both Ia- and HTA-posit ive cells are 
increased but not to levels as high as that seen in contact 
dermatit is and once again the ratio of double-stained cells to 
those staining with only HTA is maintained. Double staining 
with both OKT3 and eit her Ia or HT A again rules out the 
possibili ty that any of our apparently dendri tic cells are acti-
vated T lymphocytes. 
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After PUV A therapy t he numbers of stained dendritic cells 
fa ll to levels slightly below normal and once again t he ratio of 
dendrit ic cells stained is maintained. In t he 4 patients from 
whom paired biopsy samples are ava ilable the fa ll in both !a-
and HTA-posit ive cells in t he 2 PUVA-treated patients con-
trasts wit h t he rise in both populations in 2 patients with 
progressive un treated disease. T hese fi gu res would suggest that 
a relative reduction in the numbers of dendri t ic !a-positive 
ant igen-present ing ce lls in t he epidermis may in part be re-
sponsible fo r the symptomatic relief afforded by PUV A t herapy. 
The po ikilodermatous mycosis fungoides group shows t he 
most striking di fference in Ia- and HTA-stained cells in t hat 
no !a-posit ive dendri tic cells can be clearly delineated in t his 
group. Despite t his there is striking uni form and intense sta in-
ing of keratinocyte membranes with Ia ant ibody and a signifi-
cant elevation of HTA-positive cells by comparison with nor-
mal skin . Clinical diffe rences between poiki lodermatous and 
plaque mycosis fungoides are usually striking and our resul ts 
suggest that di fferent mediators may be at work, leading in t he 
first case to dermal thinning and vasodilatation and in t he 
second to relative acanthosis. Our present study might suggest 
t hat within the epidermis there are di fferences in membrane 
markers of dendri t ic cell s which may in turn lead to diffe rences 
in functional interactions among keratinocytes, dendritic ce lls, 
and lymphocyte subsets . 
T he observation of epidermal keratinocyte membrane stain-
ing with Ia ant ibody is of considerable interest and t his wou ld 
appear to be t he fi rst report of Ia staining of keratinocytes in 
human allergic contact dermatitis. Ia ant igen is not found on 
normal human epidermal cells but T jernlund et a! have ob-
served posit ive staining on keratinocytes in t he skin of mycosis 
fungoides [12] and there are recent reports of the presence of 
Ia ant igen in graft-versus-host disease keratinocytes [13,14]. 
The source of t his Ia ant igen is not yet known but it may be 
t hat under certain stimuli t he ep idermal keratinocyte can, like 
t he T lymphocyte, be provoked to synthesis and express Ia 
antigen. On the other hand, this may be just a "leakage and 
coating phenomenon" with excessive production of Ia ant igen 
by epidermal Langerhans cell s and subsequent passive coating 
of surrounding keratinocytes. In either case, however, the end 
result is a significant increase in the number of !a-positive 
cells. If all such cells are capable of ant igen presentation, th is 
phenomenon could expla in in part the chronicity of many sk in 
diseases. 
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Fibrous Proteins of Bovine Hoof 
HOWARD P. BADEN, M .D. AND JOSEPH KUBILUS, PH .D. 
Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, U.S.A. 
The matrix region of calf hoof was identified as the 
living precursor layer of the hardened hoof plate. Fi-
brous protein was isolated from the matrix with citrate 
buffer, pH. 2.65, while Tris buffer, pH. 9.5, with 8 M 
urea and a reducing agent was required to dissolve the 
cornified hoof. The purified matrix protein had a sodium 
dodecyl sulfate-polyacrylamide gel electrophoretic pat-
tern similar to hoof plate and different from bovine 
epidermis. When the s-carboxymethyl derivatives of 
matrix, hoof plate, and hair proteins was compared by 
urea-polyacrylamide gel electrophoresis, they were 
identical, and different from that of epidermal protein. 
The matrix protein reacted with an antibody to hair 
fibrous protein. Cultured matrix keratinocytes ap-
peared to be identical to cultured epidermal cells, point-
ing to the importance of the dermis in epidermal cell 
differentiation. 
Matoltsy [1] observed that the fibrous proteins of the living 
laye rs of cow snout epidermis could be solubilized by citrate 
buffers and subsequent investigators showed that it consisted 
of a number of polypeptides t hat could be separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) [2-4]. This protein, prekeratin, was totally reduced and 
became oxidized to yield the disulfide cross-linked fibrous pro-
tein of the stratum corneum [4,5]. Studies of the epidermis of 
a number of animals yielded simi lar results, suggesting t hat 
synthesis of a reduced acid buffer-soluble protein in the mal-
pighian layer followed by posttranslation modification to give 
stratum corneum fibrous protein was a general phenomenon 
[6,7] . 
The fibrous proteins of fu lly formed hair and nails are present 
in the oxidized disulfide form and are soluble only in an alkaline 
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denaturing buffer containing a reducing agent [8,9]. Electro-
phoretic separation of the fibrous polypeptides is commonly 
performed with the s-carboxymethyl (SCM) derivatives using 
polyacrylamide gels containing urea at alkaline pH [10,11]. 
Precursors of the fibrous proteins have been isolated from the 
follicle using buffers containing only urea, but electrophoretic 
analysis has been done on the SCM derivatives as described 
above [12]. Chemical analyses of the fibrous polypeptides ap-
pearing as single bands in the polyacrylamide urea gels have 
suggested they are heterogeneous consisting of several compo-
nents [13]. Furthermore, M,heterogeneity of these components 
has been demonstrated by doing SDS-PAGE in a second direc-
tion [14]. 
This report describes t he isolation of fibrous proteins from 
bovine hoof and reveals that the polypeptides of the living 
matrix cells are present in t he reduced form and can be solu-
bilized by citrate buffer, pH 2.65, similar to that which has 
been described for epidermal prekeratin. These polypeptides 
then undergo oxidation to yield the disulfide cross-linked pro-
tein of the nail plate. 
MATERIALS AND METHODS 
Snouts and hooves were obtained from fresh ly slaughtered calves 
and stored on ice until used. Epidermis was removed from the snouts 
by slicing with a razor. The perihoof skin and matrix regions (see Fig 
1) were carefully dissected to avoid any contamination of one with the 
other. This was checked by histologic examination of the specimens. 
The cuticle was scraped off the top of the matrix specimens. The 
specimens were soaked in 0.24 M NH 4Cl, pH 9.5, for 30 min at 4"C to 
separate the epidermis and matrix from the dermis, which was dis-
carded. This separated tissue was homogenized with a Virtis homoge-
nizer in 0.1 M citrate buffer, pH 2.65, at O"C, stirred at 4 "C for 3 h, and 
centrifuged at 30,000 g. The fibrous protein was purified from the clear 
supernatant by precipitation at pH 7.0 and 6.0, and stored at -70"C. 
The undissolved pellet was reextracted with citrate buffer and t hen 
stirred for 24 h with 0.2 M Tris, pH 9.5, with 8 M urea for 24 h at room 
temperature. The suspension ·was centrifuged at 30,000 g, and the pellet 
stirred in t he same buffer with 0.2 M mercaptoethanol for 24 h at room 
temperature under nitrogen and t hen centrifuged at 30,000 g. The Tris-
urea-mercaptoethanol (TUM) extracts were dia lyzed against 0.05 M 
Tris-acetate buffer, pH 7.5, and the precipitates collected by centrifu-
gation and stored at -70"C. Aliquots of the citrate and TUM buffer-
soluble proteins were alkylated with iodoacetic acid as previously 
described to form the SCM derivatives [11] . The SCM fibrou s proteins 
was purified by precipitation at pH 4.5. 
Hairs were plucked from the skin around the nose and the bulb ends 
and attac hed root sheaths cut off and extracted as described for 
epidermis. The remainder of the hair and pieces of horny tissue shaved 
